Commentary: Bettering BCG: a tough task for a TB vaccine?
Brahm S Srivastava, Vipul K Singh, Vivek K Kashyap, Ranjana Srivastava, Arshad Khan, Chinnaswamy Jagannath
Author Information
- Brahm S Srivastava: Nextec Lifesciences, Lucknow, India.
- Vipul K Singh: Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, United States.
- Vivek K Kashyap: Department of Immunology and Microbiology, University of Texas Rio Grande Valley, McAllen, TX, United States.
- Ranjana Srivastava: Nextec Lifesciences, Lucknow, India.
- Arshad Khan: Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, United States.
- Chinnaswamy Jagannath: Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, United States.
No abstract text available.
- Lancet. 2013 Mar 23;381(9871):1021-8
[PMID: 23391465]
- Tuberculosis (Edinb). 2008 May;88(3):171-7
[PMID: 18054522]
- Tuberculosis (Edinb). 2008 Nov;88(6):518-25
[PMID: 18434250]
- Vaccine. 2011 Jun 24;29(29-30):4754-60
[PMID: 21565242]
- Infect Immun. 2008 Jan;76(1):127-40
[PMID: 17938218]
- Tuberculosis (Edinb). 2014 May;94(3):252-61
[PMID: 24631199]
- J Bacteriol. 2009 Aug;191(16):5037-43
[PMID: 19525349]
- Nat Med. 2013 Apr;19(4):410-1
[PMID: 23558628]
- J Biol Chem. 2006 Feb 17;281(7):3866-75
[PMID: 16354661]
- Int J Antimicrob Agents. 2013 Jul;42(1):27-35
[PMID: 23684389]
- Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):535-43
[PMID: 26810060]
- Microbes Infect. 2005 Mar;7(3):349-55
[PMID: 15777648]
- Microbiology. 2007 Mar;153(Pt 3):659-66
[PMID: 17322185]
BCG Vaccine
Mycobacterium bovis
